ArticleRespiratory medicine case reports2024
Successful treatment of a patient with NSCLC carrying uncommon compound L861Q/G719X epidermal growth factor receptor mutations using Afatinib.
Zihan Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.